» Articles » PMID: 21496013

Astrocyte Phenotypes and Their Relationship to Myelination

Overview
Journal J Anat
Date 2011 Apr 19
PMID 21496013
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocytes are one of the major glial cell types that maintain homeostasis in the undamaged CNS. After injury and disease, astrocytes become reactive and prevent regeneration; however, it has also been suggested that astrocytes can become activated and promote regeneration. Thus, it is hypothesised that astrocytes have an important role in modulating CNS repair. This review will focus on the variable phenotypic state of astrocytes that range from inactive/quiescent to reactive, and relate these to their ability to influence myelination. Using myelinating cultures plated on astrocytes we propose a possible mechanism for oligodendrocyte precursor cell interaction with the axon, leading to myelination. The phenotypic status of astrocytes is an intriguing and widely discussed issue, which is critical for understanding the mechanisms involved in CNS injury and its subsequent repair.

Citing Articles

Modulation of αv integrins by lebecetin, a viper venom-derived molecule, in experimental neuroinflammation and demyelination models.

Neili N, AbdelKafi-Koubaa Z, Jebali J, Kaidi K, Sahraoui G, Ben Ahmed M Sci Rep. 2024; 14(1):22398.

PMID: 39333683 PMC: 11436777. DOI: 10.1038/s41598-024-73259-1.


Exploring neuroglial signaling: diversity of molecules implicated in microglia-to-astrocyte neuroimmune communication.

Mohammad Z, Yudin S, Goldberg B, Serra K, Klegeris A Rev Neurosci. 2024; 36(1):91-117.

PMID: 39240134 PMC: 11717358. DOI: 10.1515/revneuro-2024-0081.


Neuron-astrocyte omnidirectional signaling in neurological health and disease.

Pathak D, Sriram K Front Mol Neurosci. 2023; 16:1169320.

PMID: 37363320 PMC: 10286832. DOI: 10.3389/fnmol.2023.1169320.


Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction.

S Ng N, Newbery M, Touffu A, Maksour S, Chung J, Carroll L CNS Neurosci Ther. 2023; 29(9):2481-2497.

PMID: 36971196 PMC: 10401142. DOI: 10.1111/cns.14190.


The therapeutic potential of triptolide and celastrol in neurological diseases.

Cui Y, Jiang X, Feng J Front Pharmacol. 2022; 13:1024955.

PMID: 36339550 PMC: 9626530. DOI: 10.3389/fphar.2022.1024955.


References
1.
Fitch M, Silver J . CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol. 2007; 209(2):294-301. PMC: 2268907. DOI: 10.1016/j.expneurol.2007.05.014. View

2.
Barrett C, DONATI E, Guth L . Differences between adult and neonatal rats in their astroglial response to spinal injury. Exp Neurol. 1984; 84(2):374-85. DOI: 10.1016/0014-4886(84)90234-6. View

3.
Dziewulska D, Jamrozik Z, Podlecka A, Rafalowska J . Do astrocytes participate in rat spinal cord myelination?. Folia Neuropathol. 1999; 37(2):81-6. View

4.
Fedoroff S, White R, Neal J, Subrahmanyan L, Kalnins V . Astrocyte cell lineage. II. Mouse fibrous astrocytes and reactive astrocytes in cultures have vimentin- and GFP-containing intermediate filaments. Brain Res. 1983; 283(2-3):303-15. DOI: 10.1016/0165-3806(83)90187-6. View

5.
John G, Lee S, Brosnan C . Cytokines: powerful regulators of glial cell activation. Neuroscientist. 2003; 9(1):10-22. DOI: 10.1177/1073858402239587. View